表紙
市場調査レポート

収縮期高血圧:世界の治験レビュー

Systolic Hypertension Global Clinical Trials Review, H2, 2014

発行 GlobalData 商品コード 315202
出版日 ページ情報 英文 98 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.50円で換算しております。
Back to Top
収縮期高血圧:世界の治験レビュー Systolic Hypertension Global Clinical Trials Review, H2, 2014
出版日: 2014年09月30日 ページ情報: 英文 98 Pages
概要

当レポートでは、収縮期高血圧に関する臨床研究の最新動向について分析し、疾患治療法の概要や、治験における主要国、G7諸国およびE7(新興7カ国)における治験数および被験者採用の状況、フェーズ(相)段階別の進行状況、有望なスポンサー、各企業研究機関での研究の進行状況、有望な薬剤の比較といった情報をまとめてお届けします。

目次

イントロダクション

  • 収縮期高血圧
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • アジア太平洋の主要5ヶ国における治験件数
    • 欧州の主5ヶ要国における治験件数
    • 北米の主要国における治験件数
    • 中東およびアフリカの主要国における治験件数
    • 中南米の主要国における治験件数

G7諸国での治験件数:心血管系疾患の治験件数に対する収縮期高血圧の治験件数比率

G7諸国での治験件数:フェーズ(相)別

G7諸国での治験件数:進捗状況別

E7諸国(新興7カ国)での治験件数:心血管系疾患の治験件数に対する収縮期高血圧の治験件数比率

E7諸国での治験件数:フェーズ(相)別

E7諸国での治験件数:進捗状況別

フェーズ(相)別の治験件数

  • 進行中の治験:フェーズ(相)別

進捗状況別の治験件数

エンドポイント達成状況別の治験件数

未達成の治験件数

一定期間に採用された被験者

スポンサーの種類別治験件数

有望なスポンサー

有望な薬剤

最新の治験情報

治験のプロファイル

  • 代表的な企業の治験概要
    • Novartis AG
    • Merck & Co., Inc.
    • Synvista Therapeutics, Inc.
    • Sanofi
    • Gilead Sciences, Inc.
    • C. H. Boehringer Sohn AG & Co. KG
    • Actavis plc
    • Serodus ASA
    • 第一三共
  • 代表的な大学・研究所における治験の概要
    • National Heart, Lung, and Blood Institute
    • Wayne State University
    • Katholieke Universiteit Leuven
    • St. John's Health System
    • University of Chicago
    • University of Connecticut Health Center
    • University of Dundee
    • CAMC Health System
    • Monash University
    • University of Minnesota

5つの代表的な治験のプロファイル

付録

図表一覧

目次

GlobalData's clinical trial report, "Systolic Hypertension Global Clinical Trials Review, H2, 2014" provides data on the Systolic Hypertension clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Systolic Hypertension. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Systolic Hypertension. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Systolic Hypertension
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Systolic Hypertension to Cardiovascular Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Systolic Hypertension to Cardiovascular Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Systolic Hypertension
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Systolic Hypertension Therapeutics Clinical Trials
  • Prominent Drugs
  • Latest Clinical Trials News on Systolic Hypertension
    • Sep 09, 2014: Serodus Announces Positive Phase IIa Clinical Study Results On SER100 In Patients with Systolic Hypertension
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • Merck & Co., Inc.
      • Clinical Trial Overview of Merck & Co., Inc.
      • Synvista Therapeutics, Inc.
      • Clinical Trial Overview of Synvista Therapeutics, Inc.
      • Sanofi
      • Clinical Trial Overview of Sanofi
      • Gilead Sciences, Inc.
      • Clinical Trial Overview of Gilead Sciences, Inc.
      • C. H. Boehringer Sohn AG & Co. KG
      • Clinical Trial Overview of C. H. Boehringer Sohn AG & Co. KG
      • Actavis plc
      • Clinical Trial Overview of Actavis plc
      • Serodus ASA
      • Clinical Trial Overview of Serodus ASA
      • Daiichi Sankyo Company, Limited
      • Clinical Trial Overview of Daiichi Sankyo Company, Limited
    • Clinical Trial Overview of Top Institutes / Government
      • National Heart, Lung, and Blood Institute
      • Clinical Trial Overview of National Heart, Lung, and Blood Institute
      • Wayne State University
      • Clinical Trial Overview of Wayne State University
      • Katholieke Universiteit Leuven
      • Clinical Trial Overview of Katholieke Universiteit Leuven
      • St. John's Health System
      • Clinical Trial Overview of St. John's Health System
      • University of Chicago
      • Clinical Trial Overview of University of Chicago
      • University of Connecticut Health Center
      • Clinical Trial Overview of University of Connecticut Health Center
      • University of Dundee
      • Clinical Trial Overview of University of Dundee
      • CAMC Health System
      • Clinical Trial Overview of CAMC Health System
      • Monash University
      • Clinical Trial Overview of Monash University
      • University of Minnesota
      • Clinical Trial Overview of University of Minnesota
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Systolic Hypertension Therapeutics, Global, Clinical Trials by Region, 2014*
  • Systolic Hypertension Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Systolic Hypertension Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Systolic Hypertension Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Systolic Hypertension Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Systolic Hypertension Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Systolic Hypertension Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Systolic Hypertension Therapeutics Clinical Trials, Central and South America, Top Countries, 2014*
  • Proportion of Systolic Hypertension to Cardiovascular Clinical Trials, G7 Countries (%), 2014*
  • Systolic Hypertension Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Systolic Hypertension Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Systolic Hypertension to Cardiovascular Clinical Trials, E7 Countries (%), 2014*
  • Systolic Hypertension Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Systolic Hypertension Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Systolic Hypertension Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Systolic Hypertension Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Systolic Hypertension Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Systolic Hypertension Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Systolic Hypertension Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Systolic Hypertension Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Systolic Hypertension Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Systolic Hypertension Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Systolic Hypertension Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Systolic Hypertension Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Systolic Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014*
  • Systolic Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014*
  • Systolic Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Synvista Therapeutics, Inc., 2014*
  • Systolic Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014*
  • Systolic Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Gilead Sciences, Inc., 2014*
  • Systolic Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG & Co. KG, 2014*
  • Systolic Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Actavis plc, 2014*
  • Systolic Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Serodus ASA, 2014*
  • Systolic Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2014*
  • Systolic Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2014*
  • Systolic Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Wayne State University, 2014*
  • Systolic Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Katholieke Universiteit Leuven, 2014*
  • Systolic Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by St. John's Health System, 2014*
  • Systolic Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Chicago, 2014*
  • Systolic Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Connecticut Health Center, 2014*
  • Systolic Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Dundee, 2014*
  • Systolic Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by CAMC Health System, 2014*
  • Systolic Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Monash University, 2014*
  • Systolic Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Minnesota, 2014*

List of Figures

  • Systolic Hypertension Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Systolic Hypertension Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Systolic Hypertension Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Systolic Hypertension Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Systolic Hypertension Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Systolic Hypertension Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Systolic Hypertension Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014*
  • Systolic Hypertension Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014*
  • Proportion of Systolic Hypertension to Cardiovascular Clinical Trials, G7 Countries (%), 2014*
  • Systolic Hypertension Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Systolic Hypertension Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Systolic Hypertension to Cardiovascular Clinical Trials, E7 Countries (%), 2014*
  • Systolic Hypertension Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Systolic Hypertension Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Systolic Hypertension Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Systolic Hypertension Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Systolic Hypertension Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Systolic Hypertension Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Systolic Hypertension Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Systolic Hypertension Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Systolic Hypertension Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Systolic Hypertension Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Systolic Hypertension Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top